Procter & Gamble Co. CFO Andre Schulten sold 33,624 shares of the company’s common stock on November 4, 2026, for a total of $5.55 million. The shares were sold at $165 each, following the exercise of stock options that allowed him to acquire the same number of shares at $91.07 per share.
After these transactions, Schulten directly holds 65,618 shares of Procter & Gamble common stock, with an additional 7,604 shares indirectly owned through a retirement plan trustee.
In other recent developments, Procter & Gamble completed two significant public offerings of senior notes. The company issued €3.25 billion in notes across four tranches, including €750 million of 3.750% notes due in 2030 and €1 billion of 4.100% notes due in 2034. Additionally, it closed a $4 billion notes offering, featuring $750 million of 5.125% notes due in 2031 and $1.25 billion of 5.450% notes due in 2036.
Analysts have also weighed in on Procter & Gamble’s performance. Piper Sandler raised its price target to $167, maintaining a Neutral rating due to strong organic sales momentum. TD Cowen increased its price target to $166, citing robust first-quarter performance and potential for higher full-year sales and earnings per share. Morgan Stanley took an even more optimistic view, raising its price target to $185 with an Overweight rating, highlighting a 6% profit and earnings per share upside in the first quarter.